These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11288125)

  • 1. Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia.
    Masturzo B; Hyett JA; Kalache KD; Rumsby G; Jauniaux E; Rodeck CH
    Prenat Diagn; 2001 Apr; 21(4):314-6. PubMed ID: 11288125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased first-trimester nuchal translucency as a prenatal manifestation of salt-wasting congenital adrenal hyperplasia.
    Fincham J; Pandya PP; Yuksel B; Loong YM; Shah J
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):392-4. PubMed ID: 12383325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enlarged adrenal glands as a prenatal marker of congenital adrenal hyperplasia: a report of two cases.
    Esser T; Chaoui R
    Ultrasound Obstet Gynecol; 2004 Mar; 23(3):293-7. PubMed ID: 15027021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
    Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.
    Cerame BI; Newfield RS; Pascoe L; Curnow KM; Nimkarn S; Roe TF; New MI; Wilson RC
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3129-34. PubMed ID: 10487675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
    Souka AP; Krampl E; Bakalis S; Heath V; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):9-17. PubMed ID: 11489218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonography in prenatal diagnosis of congenital adrenal hyperplasia.
    Saada J; Grebille AG; Aubry MC; Rafii A; Dumez Y; Benachi A
    Prenat Diagn; 2004 Aug; 24(8):627-30. PubMed ID: 15305351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.
    Souka AP; Krampl E; Geerts L; Nicolaides KH
    Prenat Diagn; 2002 Feb; 22(2):91-2. PubMed ID: 11857608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    Nimkarn S; New MI
    Horm Res; 2007; 67(2):53-60. PubMed ID: 17047340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.
    Miller WL
    J Urol; 1999 Aug; 162(2):537-40. PubMed ID: 10411085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonographic diagnosis of fetal adrenal hyperplasia: utility for prenatal corticotherapy.
    Cassart M; Massez A; Donner C; Heinrichs C; Avni F
    Prenat Diagn; 2005 Nov; 25(11):1060-1. PubMed ID: 16299831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.